Moderna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna (MRNA) spreader of 1K contracts of September 25 weekly 157.50 and 165 calls as share price up 10.5%
- Ally CFO: Still Expecting To Deliver In Range Of NIM Guidance - Bloomberg
- Moderna shares gain on momentum and short squeeze
Create E-mail Alert Related Categories
Guidance, Hot Guidance, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
